In the original article, there was a mistake in Figure 6 as published. The labels “ATP hydrolysis” and “ATP binding” were inverted; the corrected Figure 6 appears below. The error does not change the scientific conclusions of the article in any way.
Figure 6

Mechanotransmission mechanism of MacB. ATP binding and hydrolysis cause large, transmembrane conformational changes in MacB structure. Rather than transporting substrates across the inner membrane, MacB-like proteins coordinate reversible dimerization of their NBDs with periplasmic conformational changes. TEP-forming MacB homologs use periplasmic conformational change to drive substrates across the bacterial outer membrane via TolC-like exit ducts. MacB homologs that do not form TEPs are proposed to use similar motions during lipoprotein trafficking and transmembrane signaling. Adapted from Crow et al. (2017).
The original article has been updated.
Statements
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1
CrowA.GreeneN. P.KaplanE.KoronakisV. (2017). Structure and mechanotransmission mechanism of the MacB ABC transporter superfamily. Proc. Natl. Acad. Sci. U.S.A.114, 12572–12577. 10.1073/pnas.1712153114
Summary
Keywords
antibiotic resistance, tripartite efflux pump, MacB, mechanotransmission, ABC transporter, lantibiotic, membrane protein, antimicrobial resistance
Citation
Greene NP, Kaplan E, Crow A and Koronakis V (2018) Corrigendum: Antibiotic Resistance Mediated by the MacB ABC Transporter Family: A Structural and Functional Perspective. Front. Microbiol. 9:2318. doi: 10.3389/fmicb.2018.02318
Received
13 August 2018
Accepted
11 September 2018
Published
28 September 2018
Volume
9 - 2018
Edited and reviewed by
Rustam Aminov, University of Aberdeen, United Kingdom
Updates
Copyright
© 2018 Greene, Kaplan, Crow and Koronakis.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Vassilis Koronakis vk103@cam.ac.uk
This article was submitted to Antimicrobials, Resistance and Chemotherapy, a section of the journal Frontiers in Microbiology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.